This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human LILRA1/CD85i/LIR-6 Protein, CF
catalog :
9226-T4
quantity :
50 ug
price :
349 USD
product information
brand :
R&D Systems
master code :
9226-T4
SKU :
9226-T4-050
product name :
Recombinant Human LILRA1/CD85i/LIR-6 Protein, CF
description :
The Recombinant Human LILRA1/CD85i/LIR-6 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human LILRA1/CD85i/LIR-6 Protein, CF has been validated for the following applications: Bioactivity.
target :
LIR-6/LILRA1
category :
Proteins and Enzymes
unit size :
50 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
species :
Human
observed molecular weight :
62-76 kDa, reducing conditions
theoretical molecular weight :
49 kDa
details of functionality :
Measured by its binding ability in a functional ELISA. When Recombinant Human LILRA1/CD85i/LIR-6 (Catalog # 9226-T4) is coated at 2 µg/mL, Recombinant Human Angiopoietin-like 7/ANGPTL7 (Catalog # 914-AN ) binds with an ED50 = 0.3-1.8 µg/mL.
endotoxin note :
<0.10 EU per 1 µg of the protein by the LAL method.
catalog number base :
9226-T4
accessionNumbers :
O75019
applications :
Bioactivity
source :
Mouse myeloma cell line, NS0-derived human LILRA1/CD85i/LIR-6 protein Pro17-Asn461, with a C-terminal 6-His tag
2020 USD :
349
2021 USD :
349 USD
alt names :
CD85 antigen-like family member I, CD85i, CD85i antigen, leukocyte immunoglobulin-like receptor subfamily A member 1, leukocyte immunoglobulin-like receptor subfamily A member 1 soluble isoform, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1, LIR6, LIR-6, LIR-6Leukocyte immunoglobulin-like receptor 6, LIR6MGC126563
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.